Previous 10 | Next 10 |
POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is commending the U.S. Department of Health and Human Services Office of Inspe...
POMPANO BEACH, FLORIDA., March 07, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company”) (OTCQB: BSEM), announced today that it has entered into an Agreement to acquire the majority of the assets of Auxocell Laboratories, Inc. ("Auxocellȁ...
BioStem Technologies ( OTCQB:BSEM ) said it signed a share exchange agreement to acquire back 10% of the issued and outstanding shares of its non-wholly owned subsidiary and manufacturing division. BioStem inked an agreement with M.W. Jens Realty Investments — a shareholder of...
The Company will Acquire Back 10% of Issued and Outstanding Shares of its Non-Wholly Owned Subsidiary and Manufacturing Division POMPANO BEACH, FLORIDA., Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company”) (OTCQB: BSEM...
POMPANO BEACH, FLORIDA., Feb. 01, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived tissue allografts for ad...
Pricing Provides VENDAJE TM Reimbursement in A ll MAC R egions POMPANO BEACH, FLORIDA., Jan. 24, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercializati...
POMPANO BEACH, FLORIDA., Dec. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, is pleased to announce that its common shares have been succes...
Kill Cliff FC is One of the world’s largest MMA Training Centers with More T han 80 P rofessional F ighters POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading re...
BioStem Technologies press release ( OTCPK:BSEM ): Q3 GAAP EPS of -$0.14. Revenue of $1.15M misses by $1.05M . For further details see: BioStem Technologies GAAP EPS of -$0.14, revenue of $1.15M misses by $1.05M
Company to Host a Conference Call and Webcast on November 15 , 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commerci...
News, Short Squeeze, Breakout and More Instantly...
BioStem Technologies Inc Company Name:
BSEM Stock Symbol:
OTCMKTS Market:
BioStem Technologies Inc Website:
POMPANO BEACH, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, today announced that an article validating ...
Please note: this Update is being issued for ticker indexing purposes. The content of the release itself remains the same. NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive interview with Jason Matuszewski, CEO of BioStem Technologies, Inc. ( OTC: BSE...
POMPANO BEACH, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, will sponsor the MRO Better Half Dash which will be held on May 29, 2...